Literature DB >> 17954649

The incidental indeterminate adrenal mass on CT (> 10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses.

Julie H Song1, Fakhra S Chaudhry, William W Mayo-Smith.   

Abstract

OBJECTIVE: The objective of our study was to determine whether follow-up imaging evaluation is necessary for incidentally discovered indeterminate adrenal lesions (> 10 H) on CT in patients with no known malignancy.
MATERIALS AND METHODS: A computer search of CT reports from January 2000 to December 2003 identified patients with incidentally detected, indeterminate, but benign-appearing adrenal lesions who had no known malignancy and no clinical suspicion of hyperfunctioning adrenal mass. Patients with adrenal masses diagnostic on the initial CT or heterogeneous masses were excluded. Two hundred ninety patients with 321 lesions met the study criteria. Each lesion was determined to be benign or malignant based on histopathology, characterization with diagnostic imaging studies, or a minimum of 1 year of stability on imaging follow-up or 2 years of stability on clinical follow-up.
RESULTS: Of the 321 lesions, 318 masses (99.1%) were confirmed to be benign and clinically insignificant. These included three (0.9%) histologically confirmed adenomas, 198 (61.7%) adenomas by imaging characterization, five (1.6%) other benign lesions, 71 (22.1%) masses stable on imaging follow-up, and 41 (12.8%) masses with clinical stability. There were three (0.9%) clinically unsuspected functioning masses: one cortisol-producing adenoma and two pheochromocytomas. There were no metastatic adrenal lesions, even among the 13 patients who subsequently developed malignancy elsewhere.
CONCLUSION: All of the incidentally detected adrenal masses with a CT attenuation of > 10 H were benign in patients with no known malignancy. Follow-up imaging to characterize an incidental adrenal mass appears to have a limited role in this patient cohort.

Entities:  

Mesh:

Year:  2007        PMID: 17954649     DOI: 10.2214/AJR.07.2167

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

1.  Development of automated detection of radiology reports citing adrenal findings.

Authors:  Jason J Zopf; Jessica M Langer; William W Boonn; Woojin Kim; Hanna M Zafar
Journal:  J Digit Imaging       Date:  2012-02       Impact factor: 4.056

Review 2.  The indeterminate adrenal mass.

Authors:  Barney Harrison
Journal:  Langenbecks Arch Surg       Date:  2011-09-23       Impact factor: 3.445

Review 3.  Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature.

Authors:  Asha Kandathil; Ka Kit Wong; Daniel J Wale; Maria Chiara Zatelli; Anna Margherita Maffione; Milton D Gross; Domenico Rubello
Journal:  Endocrine       Date:  2014-10-02       Impact factor: 3.633

4.  Clinical Importance of Incidentally Detected Hyperenhancing Liver Observations on Portal Venous Phase Computed Tomography in Patients Without Known Malignancy or Liver Disease.

Authors:  Michael T Corwin; Ryan T DiGeronimo; Shannon M Navarro; Ghaneh Fananapazir; Machelle Wilson; Thomas W Loehfelm
Journal:  J Comput Assist Tomogr       Date:  2021 Jul-Aug 01       Impact factor: 1.826

5.  Appendiceal Incidentalomas: Prevalence, Radiographic Characteristics, Management, and Outcomes.

Authors:  Adam Kelly; Stacy O'Connor; Diana Kane; Chiang-Ching Huang; Harveshp Mogal
Journal:  Ann Surg Oncol       Date:  2022-08-21       Impact factor: 4.339

6.  Adrenal gland abnormality detection using random forest classification.

Authors:  Ganesh Saiprasad; Chein-I Chang; Nabile Safdar; Naomi Saenz; Eliot Siegel
Journal:  J Digit Imaging       Date:  2013-10       Impact factor: 4.056

7.  Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas.

Authors:  Yoon Young Cho; Sunghwan Suh; Ji Young Joung; Hyemin Jeong; Dongmo Je; Hongseok Yoo; Taek Kyu Park; Yong-Ki Min; Kwang-Won Kim; Jae Hyeon Kim
Journal:  Korean J Intern Med       Date:  2013-08-14       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.